ALZAMEND NEURO INC's ticker is ALZN and the CUSIP is 02262M308. A total of 23 filers reported holding ALZAMEND NEURO INC in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,250 | -53.5% | 250,000 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $127,500 | +20.0% | 250,000 | 0.0% | 0.01% | +20.0% |
| Q1 2023 | $106,250 | -40.1% | 250,000 | 0.0% | 0.01% | -44.4% |
| Q4 2022 | $177,500 | -34.3% | 250,000 | 0.0% | 0.01% | -40.0% |
| Q3 2022 | $270,000 | +12.5% | 250,000 | 0.0% | 0.02% | +7.1% |
| Q2 2022 | $240,000 | -22.1% | 250,000 | 0.0% | 0.01% | -30.0% |
| Q1 2022 | $308,000 | – | 250,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 15,402 | $135,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 16,018 | $140,000 | 0.00% |
| Cubist Systematic Strategies, LLC | 23,672 | $207,000 | 0.00% |
| UBS Group AG | 2,691 | $24,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 27 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 44,600 | $389,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 57,030 | $498,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 2,045 | $18,000 | 0.00% |
| MORGAN STANLEY | 259 | $2,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 193 | $2,000 | 0.00% |